Loss of ARID1A activates mTOR signaling and SOX9 in gastric adenocarcinoma-rationale for targeting ARID1A deficiency.
Dong X, Song S, Li Y, Fan Y, Wang L, Wang R, Huo L, Scott A, Xu Y, Pizzi MP, Ma L, Wang Y, Jin J, Zhao W, Yao X, Johnson RL, Wang L, Wang Z, Peng G, Ajani JA.
Dong X, et al. Among authors: song s.
Gut. 2022 Mar;71(3):467-478. doi: 10.1136/gutjnl-2020-322660. Epub 2021 Mar 30.
Gut. 2022.
PMID: 33785559
Free PMC article.